SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-222171
Filing Date
2010-10-01
Accepted
2010-10-01 16:49:52
Documents
7
Period of Report
2010-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 23588
2 UNDERWRITING AGREEMENT, DATED SEPTEMBER 30, 2010 dex11.htm EX-1.1 284192
3 FORM OF WARRANT TO PURCHASE COMMON STOCK dex41.htm EX-4.1 70287
4 OPINION OF COOLEY LLP dex51.htm EX-5.1 10275
5 PRESS RELEASE, DATED OCTOBER 1, 2010 dex991.htm EX-99.1 7874
6 GRAPHIC g104664ex5_1logo.jpg GRAPHIC 6987
7 GRAPHIC g104664ex99_1pg1.jpg GRAPHIC 5434
  Complete submission text file 0001193125-10-222171.txt   415359
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 101103012
SIC: 2834 Pharmaceutical Preparations